Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classical papillary thyroid carcinoma?

CONCLUSIONS: When other clinicopathological factors were similar, patients with TCV did not exhibit unfavorable clinical outcome whereas those with CCV had significantly poorer clinical outcome. Individualized therapeutic approach might be necessary for each type of AV-PTCs. PMID: 29875289 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29875289?dopt=Abstract

Source: European Journal of Endocrinology - June 6, 2018 Category: Endocrinology Authors: Song E, Jeon MJ, Oh HS, Han M, Lee YM, Kim TY, Chung KW, Kim WB, Shong YK, Song DE, Kim WG Tags: Eur J Endocrinol Source Type: research